Vasilyev KA - Search Results

1

TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis.

Shurygina AS, Zabolotnykh NV, Vinogradova TI, Vitovskaya ML, Dogonadze MZ, Vasilyev KA, Buzitskaya ZV, Yablonskiy PK, Lioznov DA, Stukova MA. Shurygina AS, et al. Among authors: vasilyev ka. Pharmaceutics. 2024 Jun 25;16(7):857. doi: 10.3390/pharmaceutics16070857. Pharmaceutics. 2024. PMID: 39065554 Free PMC article.

2

Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs.

Sergeeva M, Romanovskaya-Romanko E, Zabolotnyh N, Pulkina A, Vasilyev K, Shurigina AP, Buzitskaya J, Zabrodskaya Y, Fadeev A, Vasin A, Vinogradova TI, Stukova MA. Sergeeva M, et al. Vaccines (Basel). 2021 Apr 16;9(4):394. doi: 10.3390/vaccines9040394. Vaccines (Basel). 2021. PMID: 33923548 Free PMC article.

3

Enhancement of the Local CD8⁺ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens.

Vasilyev K, Shurygina AP, Zabolotnykh N, Sergeeva M, Romanovskaya-Romanko E, Pulkina A, Buzitskaya J, Dogonadze MZ, Vinogradova TI, Stukova MA. Vasilyev K, et al. Vaccines (Basel). 2021 Nov 3;9(11):1273. doi: 10.3390/vaccines9111273. Vaccines (Basel). 2021. PMID: 34835204 Free PMC article.

4

Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.

Shurygina AP, Zabolotnykh N, Vinogradova T, Khairullin B, Kassenov M, Nurpeisova A, Sarsenbayeva G, Sansyzbay A, Vasilyev K, Buzitskaya J, Egorov A, Stukova M. Shurygina AP, et al. Int J Mol Sci. 2023 Apr 18;24(8):7439. doi: 10.3390/ijms24087439. Int J Mol Sci. 2023. PMID: 37108602 Free PMC article.

5

Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.

Vasilyev K, Shurygina AP, Sergeeva M, Stukova M, Egorov A. Vasilyev K, et al. Microorganisms. 2021 Mar 26;9(4):690. doi: 10.3390/microorganisms9040690. Microorganisms. 2021. PMID: 33810549 Free PMC article.

6

Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2.

Krasilnikov IV, Kudriavtsev AV, Vakhrusheva AV, Frolova ME, Ivanov AV, Stukova MA, Romanovskaya-Romanko EA, Vasilyev KA, Mushenkova NV, Isaev AA. Krasilnikov IV, et al. Among authors: vasilyev ka. Vaccines (Basel). 2022 Jan 2;10(1):69. doi: 10.3390/vaccines10010069. Vaccines (Basel). 2022. PMID: 35062730 Free PMC article.

7

Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1).

Goncharov NV, Vasilyev KA, Kudryavtsev IV, Avdonin PP, Belinskaia DA, Stukova MA, Shamova OV, Avdonin PV. Goncharov NV, et al. Among authors: vasilyev ka. J Evol Biochem Physiol. 2022;58(1):230-246. doi: 10.1134/S0022093022010203. Epub 2022 Mar 5. J Evol Biochem Physiol. 2022. PMID: 35283537 Free PMC article.

8

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.

Pulkina A, Vasilyev K, Muzhikyan A, Sergeeva M, Romanovskaya-Romanko E, Shurygina AP, Shuklina M, Vasin A, Stukova M, Egorov A. Pulkina A, et al. Int J Mol Sci. 2023 Jul 14;24(14):11445. doi: 10.3390/ijms241411445. Int J Mol Sci. 2023. PMID: 37511205 Free PMC article.

9

Meglumine acridone acetate, the ionic salt of CMA and N-methylglucamine, induces apoptosis in human PBMCs via the mitochondrial pathway.

Plotnikova MA, Klotchenko SA, Kiselev AA, Gorshkov AN, Shurygina AS, Vasilyev KA, Uciechowska-Kaczmarzyk U, Samsonov SA, Kovalenko AL, Vasin AV. Plotnikova MA, et al. Among authors: vasilyev ka. Sci Rep. 2019 Dec 3;9(1):18240. doi: 10.1038/s41598-019-54208-9. Sci Rep. 2019. PMID: 31796757 Free PMC article.

10

Erratum to: Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1).

Goncharov NV, Vasilyev KA, Kudryavtsev IV, Avdonin PP, Belinskaia DA, Stukova MA, Shamova OV, Avdonin PV. Goncharov NV, et al. Among authors: vasilyev ka. J Evol Biochem Physiol. 2022;58(2):623. doi: 10.1134/S0022093022020284. Epub 2022 May 16. J Evol Biochem Physiol. 2022. PMID: 35599638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters